Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
about
Budesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisCombination therapy for the treatment of Crohn's disease.Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel DiseaseQuality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn DiseaseOptimizing the Use of Biologic Therapies in the Management of Inflammatory Bowel Disease.M1 Macrophages Activate Notch Signalling in Epithelial Cells: Relevance in Crohn's Disease.Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agents.Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's disease.An update on medical management on Crohn's disease.Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.Early Epithelial Restitution by Nonsteroidal Anti-Inflammatory Drug-Activated Gene 1 Counteracts Intestinal Ulcerative Injuries.Clinical trials in ulcerative colitis: a historical perspective.Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines.Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.Endoscopic Disease Activity in Inflammatory Bowel Disease.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.MMX® technology and its applications in gastrointestinal diseases.How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.Assessment of histological remission in ulcerative colitis: discrepancies between daily practice and expert opinion.How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.New Trends in Inflammatory Bowel Disease.Caudal type homeobox 2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitis.GART mediates the renewal of intestinal epithelial barrier via p38/p53/PUMA cascade in colitis.Endocytoscopic classification can be predictive for relapse in ulcerative colitis.Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis.Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing.An objective in vivo diagnostic method for inflammatory bowel disease.SMAD4 Protein Expression Is Downregulated in Ileal Epithelial Cells from Patients with Crohn's Disease with Significant Inverse Correlation to Disease Activity.
P2860
Q26779042-71F93FA3-A290-4ED3-9937-32FE214C1A02Q35714202-524032F3-1D30-47A9-9112-D602FF55416DQ36433675-4D6DCDF4-2389-4858-8C07-BB7BC53603F4Q36838154-C9949817-3579-424D-BB22-BFAB6646C00EQ36848459-3C254287-F51D-43EF-B702-E2B2DC68D2B6Q37118414-9B287081-FF70-4F0C-9144-303AB2E99EB4Q37306556-1DE6115B-A939-4AEB-A430-6AAA298F6DACQ37553641-69D18C25-FCF1-4623-9D4D-938A0535FE2CQ38270674-BECCD287-EE8B-4C6C-B08C-F5369185E0BFQ38396153-13AF7892-9CF1-4F88-A236-F1BBEA754835Q38412532-32923499-C13D-4DF0-A0AB-4897BB4E81C6Q38443024-7178AD1C-CF31-4499-9489-2844FB0E083EQ38596171-0F803EBF-C8DA-415D-91F2-345D967DB97CQ38625896-A2B623F4-7AC8-4309-A53F-F26AE0A45EE5Q38664077-3083E02B-9755-4D9B-A638-50E4BF6F3F8FQ38694153-F4550528-7C0E-4726-A4FB-87B5DE25DB81Q38768496-76B23FCE-29A2-4250-A187-0050C4EE5A12Q39120033-6CEC954C-EE37-4496-A2DC-FA4D2E176031Q40095211-F90BF44A-B223-431A-A18A-4F09866678BBQ41319565-5D46CA61-B949-4D9A-83CD-F47CAD6EA93AQ42409308-D2F2E5E8-3D52-4B85-990E-F8858D704042Q46934021-51E3DC79-1B3A-4A6F-B76E-B8D8937F7141Q47310047-70A97187-5F07-4C87-9787-F88A5B4DFB59Q49683840-A00D9E41-7A5E-4351-AD43-FAE477167037Q50510379-CCEEBBAB-B741-4397-8C55-EFDD20091EF0Q50979274-CD05D4E6-8D63-475B-BF29-B372E72E9EA3Q51318566-1097E741-2B49-4362-A19A-185A0C437666Q51415373-0C41CFD5-4CE6-45FE-BE3B-E49374B72BD2Q51735292-C4168CED-F9B3-49BE-895F-43B042CA74C5Q52372724-217F0724-3DDC-4B55-80B8-EDA97CE2D4E4Q55029613-E58F952D-BFCB-48FD-94BD-94CCEAD8FBDDQ55361029-0F5A590C-8F36-4F24-9556-502F765E58E5Q55428206-01FDDD48-5FD0-48F4-92D4-9FD2A8FECE26
P2860
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mucosal healing as a target of ...... ods to score disease activity.
@en
type
label
Mucosal healing as a target of ...... ods to score disease activity.
@en
prefLabel
Mucosal healing as a target of ...... ods to score disease activity.
@en
P2093
P1476
Mucosal healing as a target of ...... ods to score disease activity.
@en
P2093
Alissa Walsh
Rebecca Palmer
Simon Travis
P304
P356
10.1016/J.GIEC.2014.03.005
P577
2014-05-06T00:00:00Z